Cristin-person-ID: 451024
Person

Marton König

  • Stilling:
    Tilsatt
    ved Nevrologisk avdeling ved Oslo universitetssykehus HF

Resultater Resultater

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis.

Wolf, Asia-Sophia Fumika Michaela; Ravussin, Anthony; König, Marton; Øverås, Mathias Herstad; Solum, Guri; Kjønstad, Ingrid Fadum; Chopra, Adity; Holmøy, Trygve; Harbo, Hanne-Cathrin Flinstad; Syversen, Silje Watterdal mfl.. 2023, JCI Insight. FHI, DIAKONSYK, UIO, AHUS, OUSVitenskapelig artikkel

Long-term outcome of patients treated for craniopharyngioma: a single center experience.

Frič, Radek; König, Marton; Due-Tønnessen, Bernt Johan; Ramm-Pettersen, Jon-Terje; Berg-Johnsen, Jon. 2023, British Journal of Neurosurgery. UIO, OUSVitenskapelig artikkel

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants (npj Vaccines, (2022), 7, 1, (174), 10.1038/s41541-022-00586-7).

Tran, Trung; Vaage, Eline Benno; Mehta, Adi; Chopra, Adity; Tietze, Lisa; Kolderup, Heidi Anette; Anthi, Aina Karen; König, Marton; Nygaard, Gro Owren; Lind, Andreas mfl.. 2023, npj Vaccines. FHI, UIO, OUS, UIBErrata

Safety of a third SARS CoV 2 mRNA vaccine dose in people with multiple sclerosis.

Rasmussen, Tilde; König, Marton; Lorentzen, Åslaug Rudjord; Schikora-Rustad, Stine; Berge, Tone; Holmøy, Trygve; Torkildsen, Øivind; Wergeland, Stig; Øverås, Mathias Herstad; Høgestøl, Einar A mfl.. 2022, ECTRIMS 2022. OSLOMET, UIO, SØRLAND, OUS, UIBPoster

Immunogenicity and efficacy of mRNA-COVID-19 vaccines in people with multiple sclerosis.

König, Marton; Wolf, Asia-Sophia Fumika Michaela; Ravussin, Anthony; Chopra, Adity; Tran, Trung; Torgauten, Hilde Marie; Rasmussen, Tilde; Schikora-Rustad, Stine; Øverås, Mathias Herstad; Lorentzen, Åslaug Rudjord mfl.. 2022, ECTRIMS 2022. FHI, OSLOMET, UIO, SØRLAND, AHUS, OUS, UIBPoster
1 - 5 av 44 | Neste | Siste »